GLIDE PHARMACEUTICAL TECHNOLOGIES LIMITED

Accounts Submitted

Confirmation Statement Submitted

Net assets N/A

Total assets N/A

Total Liabilities N/A

Charges 4

1 outstanding 3 satisfied

AI Analysis

Analyze director networks, ownership patterns, and company connections

CompanyTrack AI can make mistakes. Check important info.

Contact & Details

Contact

Update Details

Registered Address

Rsm Restructuring Advisory Llp 3 Hardman Street Manchester M3 3HF

Office ()

Abingdon, Oxfordshire, United Kingdom, Europe

Telephone

448700853700

enquiries@glidepharma.com

Website

glide-technologies.com

Credit Report

Discover GLIDE PHARMACEUTICAL TECHNOLOGIES LIMITED's Credit Score, limit, and payment likelihood.

Mutual Companies

See All Mutual Companies

Financials

No accounts filed yet

Financial History

Revenue, profit, EBITDA and key financial figures

No Financial Data Available

Financial information will appear here once available.

Funding

Fundraising & Grants

No fundraising or grants recorded

Investors (0)

No investor information available

Share Capital

Share allotments and capital structure

2 Allotments 252,950 Shares £253k Total

Date From	Share Class	Shares Allotted	Amount Raised	Price/Share
19 Jan 2017	ORDINARY	213,850	£214k	£214k
19 Jan 2017	A ORDINARY	39,100	£39k	£39k

Officers

4 active 16 resigned

Show resigned officers

						Status
Fraser Andrew Skirrow	Director	British	England	62	11 Feb 2017	Active
Ian Joseph Smith	Director	British	United Kingdom	78	14 Dec 2011	Active
James Anthony Otter	Director	British	England	68	27 Apr 2017	Active
Richard Edward Bungay	Director	British	England	56	1 Jul 2014	Active

Shareholders

Shareholders (127)


Warwick Tong	0.1%	10,098	Ordinary	8 Mar 2017
Wallder Consulting Ltd	0.0%	3,846	Ordinary	8 Mar 2017
Yann Kispredilov	0.0%	353	Ordinary	8 Mar 2017

Persons with Significant Control

Persons with Significant Control (2)

2 Active

Bank Of New York (nominees) Limited

United Kingdom

Active

Notified 6 Apr 2016

Nature of Control

Ownership Of Shares 25 To 50 Percent
Voting Rights 25 To 50 Percent
Right To Appoint And Remove Directors

Anthony Rowlands

British

Active

Notified 20 Jan 2017

Residence Monaco

DOB June 1956

Nature of Control

Significant Influence Or Control

See All Controllers

Group Structure

THE BANK OF NEW YORK (NOMINEES) LIMITED united kingdom shares 75 to 100 percent, voting rights 75 to 100 percent, appoint/remove directors

THE BANK OF NEW YORK MELLON CORPORATION united states of america

GLIDE PHARMACEUTICAL TECHNOLOGIES LIMITED Current Company

Charges

1 outstanding 3 satisfied

Documents

Company Filings

Date	Category	Description	Document
20 Oct 2018	Gazette	Gazette Dissolved Liquidation	View(1 page)
20 Jul 2018	Insolvency	Liquidation In Administration Move To Dissolution	View(15 pages)
3 Jul 2018	Insolvency	Liquidation In Administration Resignation Of Administrator	View(14 pages)
3 Jul 2018	Insolvency	Liquidation In Administration Appointment Of Administrator	View
15 Mar 2018	Insolvency	Liquidation In Administration Progress Report	View(18 pages)